EU Commission releases pharma patent monitoring report
( March 9, 2018, 11:01 GMT | Official Statement) -- MLex Summary: Patent deals that see a transfer of value from the holder of a drug patent "transfer value" to a generic rival have decreased and stabilized at a low level, the European Commission said. In its eighth monitoring report of the industry, the antitrust watchdog said patent settlements were continuing, contrary to the warnings of industry, but that the number that would raise competition concerns had dropped over time.The report is attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.